Canada markets open in 2 hours 13 minutes

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
27.38+0.40 (+1.48%)
At close: 04:00PM EDT
27.91 +0.53 (+1.94%)
After hours: 05:15PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.16B
Enterprise Value 1.66B
Trailing P/E 53.69
Forward P/E 8.79
PEG Ratio (5 yr expected) 0.73
Price/Sales (ttm)1.42
Price/Book (mrq)0.74
Enterprise Value/Revenue 1.09
Enterprise Value/EBITDA 7.50

Trading Information

Stock Price History

Beta (5Y Monthly) 1.17
52-Week Change 3-30.06%
S&P500 52-Week Change 329.31%
52 Week High 346.75
52 Week Low 322.36
50-Day Moving Average 330.95
200-Day Moving Average 338.11

Share Statistics

Avg Vol (3 month) 31.08M
Avg Vol (10 day) 31.35M
Shares Outstanding 578.8M
Implied Shares Outstanding 678.8M
Float 867.69M
% Held by Insiders 113.88%
% Held by Institutions 187.53%
Shares Short (Apr 30, 2024) 42.45M
Short Ratio (Apr 30, 2024) 42.93
Short % of Float (Apr 30, 2024) 43.60%
Short % of Shares Outstanding (Apr 30, 2024) 43.11%
Shares Short (prior month Mar 28, 2024) 42.09M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Jan 04, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 2.63%
Operating Margin (ttm)10.98%

Management Effectiveness

Return on Assets (ttm)3.83%
Return on Equity (ttm)2.46%

Income Statement

Revenue (ttm)1.53B
Revenue Per Share (ttm)19.35
Quarterly Revenue Growth (yoy)-3.10%
Gross Profit (ttm)N/A
EBITDA 362.6M
Net Income Avi to Common (ttm)40.23M
Diluted EPS (ttm)0.51
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)677.29M
Total Cash Per Share (mrq)8.6
Total Debt (mrq)2.04B
Total Debt/Equity (mrq)127.94%
Current Ratio (mrq)4.68
Book Value Per Share (mrq)20.29

Cash Flow Statement

Operating Cash Flow (ttm)129.56M
Levered Free Cash Flow (ttm)166.36M